Davide Franceschini

5.5k total citations · 1 hit paper
182 papers, 3.7k citations indexed

About

Davide Franceschini is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Davide Franceschini has authored 182 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pulmonary and Respiratory Medicine, 50 papers in Radiation and 46 papers in Oncology. Recurrent topics in Davide Franceschini's work include Advanced Radiotherapy Techniques (50 papers), Lung Cancer Diagnosis and Treatment (29 papers) and Breast Cancer Treatment Studies (21 papers). Davide Franceschini is often cited by papers focused on Advanced Radiotherapy Techniques (50 papers), Lung Cancer Diagnosis and Treatment (29 papers) and Breast Cancer Treatment Studies (21 papers). Davide Franceschini collaborates with scholars based in Italy, United States and United Kingdom. Davide Franceschini's co-authors include Pietro Giusti, Marta Scorsetti, Ciro Franzese, Fiorenza De Rose, Luca Cozzi, Antonella Fogliata, Stefano Tomatis, Pierina Navarria, Tiziana Comito and Stephen D. Skaper and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Davide Franceschini

175 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway

2019 408 citations Davide Franceschini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Davide Franceschini Italy	33	1.3k	826	730	711	688	182	3.7k
Kevin R. Kozak United States	36	892 0.7×	328 0.4×	348 0.5×	797 1.1×	929 1.4×	89	4.5k
Mike E. Robbins United States	39	1.7k 1.3×	225 0.3×	1.6k 2.2×	504 0.7×	1.5k 2.2×	98	5.1k
Ahmed Eleojo Musa Iran	30	485 0.4×	38 0.0×	799 1.1×	555 0.8×	946 1.4×	64	2.6k
Yamei Tang China	32	702 0.5×	23 0.0×	301 0.4×	370 0.5×	916 1.3×	138	4.0k
Susumu Takekoshi Japan	30	143 0.1×	68 0.1×	130 0.2×	263 0.4×	941 1.4×	166	2.6k
Edwige Petit France	32	262 0.2×	25 0.0×	290 0.4×	403 0.6×	1.3k 1.9×	67	4.0k
Kooresh I. Shoghi United States	23	147 0.1×	78 0.1×	788 1.1×	169 0.2×	793 1.2×	79	2.6k
Zhiyuan Wu China	26	226 0.2×	20 0.0×	199 0.3×	276 0.4×	912 1.3×	119	2.9k
Xiao Wen Mao United States	26	290 0.2×	46 0.1×	378 0.5×	107 0.2×	530 0.8×	92	2.0k
Theodoros Tsakiridis Canada	31	285 0.2×	31 0.0×	88 0.1×	575 0.8×	2.5k 3.7×	82	3.5k

Countries citing papers authored by Davide Franceschini

Since Specialization

Citations

This map shows the geographic impact of Davide Franceschini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Franceschini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Franceschini more than expected).

Fields of papers citing papers by Davide Franceschini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Franceschini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Franceschini. The network helps show where Davide Franceschini may publish in the future.

Co-authorship network of co-authors of Davide Franceschini

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Franceschini. A scholar is included among the top collaborators of Davide Franceschini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Franceschini. Davide Franceschini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cozzi, Luca, Davide Franceschini, Luca Dominici, et al.. (2025). Cardiac Exposure Related to Adjuvant Radiotherapy in Patients Affected by Thymoma: A Dosimetric Comparison of Photon or Proton Intensity-Modulated Therapy. Cancers. 17(2). 294–294.

Franceschini, Davide, Mauro Loi, Luca Dominici, et al.. (2024). STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung Lesions. SHILAP Revista de lepidopterología. 12(7). 153–153. 2 indexed citations

Franzese, Ciro, Anna Bertolini, Davide Franceschini, et al.. (2024). Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR). Cancers. 16(17). 2963–2963. 2 indexed citations

Franceschini, Davide, Maria Ausilia Teriaca, Pietro Mancosu, et al.. (2024). Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases. Radiotherapy and Oncology. 197. 110335–110335. 3 indexed citations

Navarria, Pierina, Federico Pessina, Giuseppe Minniti, et al.. (2023). Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study. Cancers. 15(5). 1393–1393. 2 indexed citations

Rossi, Sabrina, Pierina Navarria, Elena Clerici, et al.. (2023). The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?. Cancers. 15(24). 5761–5761. 4 indexed citations

Massaro, Maria, Davide Franceschini, Ruggero Spoto, et al.. (2022). Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy. Current Oncology. 29(7). 4893–4901. 2 indexed citations

Franceschini, Davide, Tiziana Comito, Ruggero Spoto, et al.. (2022). Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial. Current Oncology. 29(10). 7858–7867. 7 indexed citations

Franceschini, Davide, Luca Cozzi, Mauro Loi, et al.. (2020). Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma. Journal of Cancer Research and Clinical Oncology. 146(9). 2267–2276. 8 indexed citations

10.

Scorsetti, Marta, Luca Cozzi, Pierina Navarria, et al.. (2020). Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin’s lymphoma. Assessment of risk of toxicity and secondary cancer induction. Radiation Oncology. 15(1). 12–12. 10 indexed citations

11.

Cozzi, Luca, Tiziana Comito, Mauro Loi, et al.. (2020). The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation. Technology in Cancer Research & Treatment. 19. 1079248060–1079248060. 2 indexed citations

12.

Franzese, Ciro, Tiziana Comito, Luca Viganò, et al.. (2020). Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer. Clinical Breast Cancer. 20(6). 480–486. 13 indexed citations

13.

Giaj‐Levra, Niccolò, Paolo Borghetti, Alessio Bruni, et al.. (2020). Current radiotherapy techniques in NSCLC: challenges and potential solutions. Expert Review of Anticancer Therapy. 20(5). 387–402. 33 indexed citations

14.

Cozzi, Luca, Tiziana Comito, Antonella Fogliata, et al.. (2019). Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma. PLoS ONE. 14(1). e0210758–e0210758. 59 indexed citations

15.

Franzese, Ciro, Tiziana Comito, A. Tozzi, et al.. (2018). Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy. Radiotherapy and Oncology. 133. 220–226. 50 indexed citations

16.

Cozzi, Luca, Antonella Fogliata, Stephen Thompson, et al.. (2018). Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate. Technology in Cancer Research & Treatment. 17. 1077071530–1077071530. 30 indexed citations

17.

Cozzi, Luca, Frank Lohr, Antonella Fogliata, et al.. (2017). Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer. Radiation Oncology. 12(1). 200–200. 26 indexed citations

18.

Pessina, Federico, Pierina Navarria, Stefano Tomatis, et al.. (2017). Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy. World Neurosurgery. 105. 184–190. 12 indexed citations

19.

D’Agostino, Giuseppe Roberto, Ciro Franzese, Fiorenza De Rose, et al.. (2016). High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. Clinical Oncology. 28(12). e173–e178. 28 indexed citations

20.

Otter, Sophie, Ulrike Schick, S. Gulliford, et al.. (2015). Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions. International Journal of Radiation Oncology*Biology*Physics. 93(3). 507–515. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact